Large-Joint Reconstructive Implants – Market Insights – Japan

The impact of COVID-19 pandemic was significant on the Japanese large-joint reconstructive implant market, limiting hip and knee replacement procedures and unit sales. Following which, favorable demographic factors and other market drivers have pushed growth in large-joint reconstructive procedure volumes; however, downward pricing pressures driven by biennial MHLW reimbursement cuts will partially offset the impact of procedural expansion on overall market revenues. Notably, significant changes in hip implant device pricing have been incorporated to align with the evolving market dynamics and reflect the changes in the overall segment market value.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for large-joint reconstructive implants in Japan from 2019 through 2032.

The complex regulatory environment continues to influence the competitive landscape in Japan.

How are the competitors performing and their forecasted position in the market?

How is the regulatory environment impacting companies’ revenues in the large-joint reconstructive implant market?

Continued negative impact on the Japanese large-joint reconstructive implant market due to biennial MHLW reimbursement cuts.

What impact do biennial MHLW reimbursement cuts have on specific device segments?

What are the factors and strategies adopted by companies to cope with the reimbursement cuts in the Japanese medical device market?

The growing adoption for advanced knee implants, 3-D printed implants, and surgical robotic platforms in the Japanese large-joint reconstructive implant market and associated launches in the forecast period.

Which market player plans to release advance knee or hip implants in the Japanese market?

How will the introduction of advanced techniques in the market impact the Japanese large-joint implant market?

Table of contents